These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3297582)

  • 1. IDDM treatment with single dose of mixture of three kinds of insulin: 2-yr follow-up.
    Quatraro A
    Diabetes Care; 1987; 10(3):379-80. PubMed ID: 3297582
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraperitoneal insulin administration does not modify plasminogen activator inhibitor 1 levels in IDDM patients.
    Raccah D; Lassmann-Vague V; Alessi MC; Juhan-Vague I; Vague P
    Diabetes Care; 1994 Aug; 17(8):941-2. PubMed ID: 7956648
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin and atheroma in IDDM.
    Joron GE; Webb JL
    Diabetes Care; 1991 Jan; 14(1):76-7. PubMed ID: 1991442
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposal of injection material used for the treatment of hepatitis C: comparison with insulin-dependent diabetes and thromboembolism.
    Causse X; D'Alteroche L; Si Ahmed SN; Giraudeau B; Metman EH;
    Gastroenterol Clin Biol; 2005 Jan; 29(1):63-8. PubMed ID: 15738897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological proteinuria in patients with insulin-dependent diabetes mellitus: relation to intensive insulin therapy.
    Chantelau E; Wichmann P
    Exp Clin Endocrinol; 1992; 99(3):164-8. PubMed ID: 1526268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDDM: day to day management.
    Samal KC; Tripathy BB
    J Assoc Physicians India; 1997; Suppl 1():21-9. PubMed ID: 11235630
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin pen-injector systems in adolescents with IDDM.
    Roe-Finlay S; Dean HJ
    Diabetes Care; 1990 Jan; 13(1):78-9. PubMed ID: 2404720
    [No Abstract]   [Full Text] [Related]  

  • 8. Complications of IDDM.
    Shaughnessy AF; Slawson DC
    J Fam Pract; 1994 Jun; 38(6):632-3. PubMed ID: 8195742
    [No Abstract]   [Full Text] [Related]  

  • 9. Long term complications of IDDM and intensified insulin treatment.
    Misra A
    Natl Med J India; 1994; 7(4):174-5. PubMed ID: 7950951
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin regimens and strategies for IDDM.
    Zinman B
    Diabetes Care; 1993 Dec; 16 Suppl 3():24-8. PubMed ID: 8299474
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy.
    Porcellati F; Fanelli C; Bottini P; Epifano L; Rambotti AM; Lalli C; Pampanelli S; Scionti L; Santeusanio F; Brunetti P
    Diabetes; 1993 Jul; 42(7):1055-64. PubMed ID: 8513972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development.
    Celi F; Bini V; Papi F; Santilli E; Ferretti A; Mencacci M; Berioli MG; De Giorgi G; Falorni A
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):139-45. PubMed ID: 16060906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
    Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
    Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin pump in the treatment of adult age diabetes].
    Sane T; Tulokas T; Nikkanen P; Heikkilä P; Huttunen E; Niskanen L
    Duodecim; 2005; 121(8):839-45. PubMed ID: 15931827
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased insulin action and clearance in hyperthyroid newly diagnosed IDDM patient. Restoration to normal with antithyroid treatment.
    Nijs HG; Radder JK; Frölich M; Krans HM
    Diabetes Care; 1989 May; 12(5):319-24. PubMed ID: 2656140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM).
    Schmitz A; Christiansen JS; Christensen CK; Hermansen K; Mogensen CE
    Dan Med Bull; 1989 Apr; 36(2):176-8. PubMed ID: 2651031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eating disorders and intentional insulin undertreatment in adolescent females with diabetes.
    Rodin G; Craven J; Littlefield C; Murray M; Daneman D
    Psychosomatics; 1991; 32(2):171-6. PubMed ID: 2027939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin synthesis is resistant to acute effects of insulin in insulin-dependent diabetes mellitus patients.
    Tuominen JA; Ebeling P; Stenman UH; Heiman ML; Stephens TW; Koivisto VA
    J Clin Endocrinol Metab; 1997 Feb; 82(2):381-2. PubMed ID: 9024222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum 1,25-dihydroxyvitamin D in insulin-dependent diabetes mellitus].
    Muñoz-Torres M; de Madrid JD; Escobar-Jiménez F; Ortego Centeno N
    Med Clin (Barc); 1990 Jul; 95(6):207-9. PubMed ID: 2250544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.
    McCulloch DK; Klaff LJ; Kahn SE; Schoenfeld SL; Greenbaum CJ; Mauseth RS; Benson EA; Nepom GT; Shewey L; Palmer JP
    Diabetes; 1990 May; 39(5):549-56. PubMed ID: 2185106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.